论文信息 - Phase 2 study of nilotinib as third‐line therapy for patients with gastrointestinal stromal tumor - 字舞流文

Phase 2 study of nilotinib as third‐line therapy for patients with gastrointestinal stromal tumor

Y. Kakeji | T. Nishida | A. Ohtsu | M. Yamasaki | T. Kanda | A. Sawaki | T. Doi | Y. Komatsu | Y. Onozawa | Y. Yamada